{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T20:45:11Z","timestamp":1773953111003,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.amjcard.2012.07.022","type":"journal-article","created":{"date-parts":[[2012,9,4]],"date-time":"2012-09-04T12:01:26Z","timestamp":1346760086000},"page":"1585-1591","source":"Crossref","is-referenced-by-count":46,"title":["Comparison of Outcomes in Patients With Versus Without Diabetes Mellitus After Revascularization With Everolimus- and Sirolimus-Eluting Stents (from the SORT OUT IV Trial)"],"prefix":"10.1016","volume":"110","clinical-trial-number":[{"clinical-trial-number":"nct00552877","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Lisette Okkels","family":"Jensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Thayssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Junker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Maeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Henrik","family":"Tilsted","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Kaltoft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Knud N\u00f8rregaard","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evald H\u00f8j","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steen Dalby","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Ravkilde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik Toft","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leif","family":"Thuesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens Flensted","family":"Lassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2012.07.022_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000315136","article-title":"Rationale and design of a randomized clinical comparison of everolimus-eluting (Xience V\/Promus) and sirolimus-eluting (Cypher Select+) coronary stents in unselected patients with coronary heart disease","volume":"116","author":"Jensen","year":"2010","journal-title":"Cardiology"},{"key":"10.1016\/j.amjcard.2012.07.022_bib2","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1161\/CIRCULATIONAHA.111.063644","article-title":"Randomized comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention: the Scandinavian Organization for Randomized Trials with Clinical Outcome IV (SORT OUT IV)","volume":"125","author":"Jensen","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2012.07.022_bib3","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2012.07.022_bib4","first-page":"263","article-title":"The Danish National Hospital Register","volume":"46","author":"Andersen","year":"1999","journal-title":"Dan Med Bull"},{"key":"10.1016\/j.amjcard.2012.07.022_bib5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.amjcard.2012.07.022_bib6","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jacc.2007.06.002","article-title":"Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions","volume":"50","author":"Jensen","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2012.07.022_bib7","first-page":"354","article-title":"The Danish registers of causes of death","volume":"46","author":"Juel","year":"1999","journal-title":"Dan Med Bull"},{"key":"10.1016\/j.amjcard.2012.07.022_bib8","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1126\/science.287.5462.2398","article-title":"Epidemiology","volume":"287","author":"Frank","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.amjcard.2012.07.022_bib9","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","article-title":"Estimation of failure probabilities in the presence of competing risks: new representations of old estimators","volume":"18","author":"Gooley","year":"1999","journal-title":"Stat Med"},{"key":"10.1016\/j.amjcard.2012.07.022_bib10","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2105\/AJPH.79.3.340","article-title":"Modeling and variable selection in epidemiologic analysis","volume":"79","author":"Greenland","year":"1989","journal-title":"Am J Public Health"},{"key":"10.1016\/j.amjcard.2012.07.022_bib11","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/eurheartj\/ehn021","article-title":"Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patients","volume":"29","author":"Billinger","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2012.07.022_bib12","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJMoa044372","article-title":"Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients","volume":"353","author":"Dibra","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2012.07.022_bib13","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehn434","article-title":"Neointimal hyperplasia after sirolimus-eluting and paclitaxel-eluting stent implantation in diabetic patients: the randomized diabetes and drug-eluting Stent (DiabeDES) intravascular ultrasound trial","volume":"29","author":"Jensen","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2012.07.022_bib14","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1016\/j.jacc.2006.01.063","article-title":"Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the Diabetes and Sirolimus-Eluting Stent","volume":"47","author":"Jimenez-Quevedo","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2012.07.022_bib15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.amjcard.2008.09.084","article-title":"Comparison of the sirolimus-eluting versus paclitaxel-eluting coronary stent in patients with diabetes mellitus: the Diabetes and Drug-Eluting Stent (DiabeDES) randomized angiography trial","volume":"103","author":"Maeng","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2012.07.022_bib16","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.amjcard.2011.06.037","article-title":"Outcome of sirolimus-eluting versus zotarolimus-eluting coronary stent implantation in patients with and without diabetes mellitus (a SORT OUT III substudy)","volume":"108","author":"Maeng","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2012.07.022_bib17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4244\/EIJV7I3A56","article-title":"Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the Diabetes and Drug-Eluting Stent (DiabeDES III) angiography and intravascular ultrasound trial","volume":"7","author":"Jensen","year":"2011","journal-title":"EuroIntervention"},{"key":"10.1016\/j.amjcard.2012.07.022_bib18","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1161\/CIRCULATIONAHA.110.015453","article-title":"Randomized comparison of everolimus-eluting stent versus sirolimus-eluting stent implantation for de novo coronary artery disease in patients with diabetes mellitus (ESSENCE-DIABETES): results from the ESSENCE-DIABETES trial","volume":"124","author":"Kim","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2012.07.022_bib19","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.jacc.2011.06.027","article-title":"Biodegradable polymer versus permanent polymer drug-eluting stents and everolimus- versus sirolimus-eluting stents in patients with coronary artery disease: 3-year outcomes from a randomized clinical trial","volume":"58","author":"Byrne","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2012.07.022_bib20","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa0910496","article-title":"Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease","volume":"362","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2012.07.022_bib21","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/j.jacc.2010.10.006","article-title":"Outcomes in diabetic and nondiabetic patients treated with everolimus- or paclitaxel-eluting stents: results from the SPIRIT IV clinical trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System)","volume":"56","author":"Kereiakes","year":"2010","journal-title":"J Am Coll Cardiol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914912018437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914912018437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T21:29:47Z","timestamp":1542749387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914912018437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0002914912018437"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2012.07.022","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717958599.793464161","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717958599.793463580","asserted-by":"object"}]},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}